Evidence map›Paper›PMID 24561552›Full record

ArticleAtherosclerosis2014

RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Aditi Shendre, Marguerite R Irvin, Bradley E Aouizerat, Howard W Wiener, Ana I Vazquez, Kathryn Anastos, Jason Lazar, Chenglong Liu, Roksana Karim, Nita A Limdi and 5 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Atherosclerosis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Aditi ShendreDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Marguerite R IrvinDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Bradley E AouizeratInstitute for Human Genetics, University of California, San Francisco, San Francisco, CA, United States; Department of Physiological Nursing, University of California, San Francisco, San Francisco, CA, United States.
Howard W WienerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ana I VazquezDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States.
Kathryn AnastosDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States.
Jason LazarDepartment of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY, United States.
Chenglong LiuDepartment of Medicine, Georgetown University Medical Center, Washington, DC, United States.
Roksana KarimAtherosclerosis Research Unit, University of Southern California, Los Angeles, CA, United States.
Nita A LimdiDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, United States.
Mardge H CohenDepartment of Medicine, John Stroger Hospital and Rush University, Chicago, IL, United States.
Elizabeth T GolubDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Degui ZhiDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States.
Robert C KaplanDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States.
Sadeep ShresthaDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: sshrestha@uab.edu.
University of Alabama at Birmingham · USAlbert Einstein College of Medicine · USGeorgetown University · USJohns Hopkins University · USRush University · USState University of New York · USUniversity of Alabama at Birmingham Hospital · USUniversity of California, San Francisco · USUniversity of Southern California · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
WOMENS INTERAGENCY HIV STUDY (WIHS)U01HD032632 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MILAM, JOEL E · 1994 to 2012
$42.0M
WIHS DATA MANAGEMENT AND ANALYSIS CENTER(WDMAC)U01AI042590 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GANGE, STEPHEN J, GOLUB, ELIZABETH T · 1998 to 2018
$38.4M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Inflammatory and Immune Mechanisms of Atherosclerosis in HIV-Infected WomenR01HL095140 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI KAPLAN, ROBERT C · 2008 to 2012
$3.8M
Mechanisms of Atherosclerosis and CVD in HIV+ WomenR01HL083760 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI KAPLAN, ROBERT C · 2006 to 2009
$2.5M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001073NCRR NIH HHS UL1 RR024131NHLBI NIH HHS 1R01HL083760).NHLBI NIH HHS 1R01HL095140NHLBI NIH HHS R01 HL083760NHLBI NIH HHS R01 HL095140NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI042590NIAID NIH HHS UO1-AI-31834NIAID NIH HHS UO1-AI-34989NIAID NIH HHS UO1-AI-34993NIAID NIH HHS UO1-AI-34994NIAID NIH HHS UO1-AI-35004NIAID NIH HHS UO1-AI-42590NICHD NIH HHS U01 HD032632NICHD NIH HHS UO1-HD-32632
6 · The paper itself

Abstract

backgroundSingle nucleotide polymorphisms (SNPs) in the Ryanodine receptor 3 (RYR3) gene are associated with common carotid intima media thickness (CCA cIMT) in HIV-infected men. We evaluated SNPs in the RYR3 gene among HIV-infected women participating in Women's Interagency HIV Study (WIHS).

methodsCCA cIMT was measured using B-mode ultrasound and the 838 SNPs in the RYR3 gene region were genotyped using the Illumina HumanOmni2.5-quad beadchip. The CCA cIMT genetic association was assessed using linear regression analyses among 1213 women and also separately among White (n=139), Black (n=720) and Hispanic (n=354) women after adjusting for confounders. A summary measure of pooled association was estimated using a meta-analytic approach by combining the effect estimates from the three races. Haploblocks were inferred using Gabriel's method and haplotype association analyses were conducted among the three races separately.

resultsSNP rs62012610 was associated with CCA cIMT among the Hispanics (p=4.41×10(-5)), rs11856930 among Whites (p=5.62×10(-4)), and rs2572204 among Blacks (p=2.45×10(-3)). Meta-analysis revealed several associations of SNPs in the same direction and of similar magnitude, particularly among Blacks and Hispanics. Additionally, several haplotypes within three haploblocks containing SNPs previously related with CCA cIMT were also associated in Whites and Hispanics. DISCUSSION: Consistent with previous research among HIV-infected men, SNPs within the RYR3 region were associated with subclinical atherosclerosis among HIV-infected women. Allelic heterogeneity observed across the three races suggests that the contribution of the RYR3 gene to CCA cIMT is complex, and warrants future studies to better understand regional SNP function.

Indexed as

Polymorphism, Single NucleotideAllelesAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveAtherosclerosisBlack or African AmericanBlack PeopleCarotid Artery, CommonCarotid Intima-Media ThicknessChromosomes, Human, Pair 15FemaleGenetic HeterogeneityHaplotypesHispanic or LatinoHIV InfectionsHumansAnti-HIV AgentsRyanodine Receptor Calcium Release ChannelCCAcIMTHIV infectionRYR3Single nucleotide polymorphismsSubclinical atherosclerosis

Identifiers

PMID24561552
PMCPMC3965606
OpenAlexW2102050857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.